How to Report Pharmacy or PBM Fraud: The Claim, the Money and What You Saw

To report pharmacy or PBM fraud, start with our whistleblower experts and the prescription, payment or reporting decision you know from inside. You may have seen a prescription returned to stock while its claim stayed paid, a cash discount disappear from government billing, or manufacturer money change categories before it reached a plan’s report. We connect what you saw to who made the decision, which payer lost money and the whistleblower case your knowledge could support.

The useful detail may be ordinary to you: which screen changed, what the reconciliation left out, or who instructed staff to keep processing the claims. That is where our conversation starts. We work with you on the evidence and strategy, then bring in pharmacy or PBM fraud whistleblower lawyers with the expertise your case needs.

What Does Pharmacy or PBM Fraud Look Like?

Pharmacy or PBM fraud includes paid claims for uncollected prescriptions, inflated cash-price reporting and hidden manufacturer rebates. This healthcare fraud takes money from taxpayers and the health care programs patients depend on. A pharmacy benefit manager processes claims and can manage pharmacy networks, formularies and manufacturer rebates. Those functions leave different records, from dispensing transactions to contract invoices and year-end reconciliations.

The medicine and the money can take different paths. A pharmacy sends a claim to a processor. A plan funds the benefit. A manufacturer may later pay a rebate through another intermediary. The person who understands the prescription may never see the rebate workbook. The person reconciling that workbook may never see the patient.

A Prescription Leaves the Queue but the Payment Stays

Uncollected prescriptions were the issue in Walgreens’ case, where the government alleged that its system moved unsold or undeleted orders after 29 days. The government alleged in the settlement agreement that Intercom Plus moved those orders to a central Unaccounted-For Status outside local work queues, without a separate back-end process to resolve them.

For someone working in the pharmacy, the important connection is between that status change and the paid claim. Pickup, shipment, return-to-stock, reversal and refund records describe different events. We want to understand what happened to the payment after the order left the store’s view.

The Cash Price and the Government Price Diverge

Usual and customary pharmacy prices were at the center of Kmart’s $32.3 million federal settlement. The Justice Department alleged that Kmart omitted broadly available discounted generic cash prices from reporting to Medicare Part D, Medicaid and TRICARE.

A pricing or billing employee may know which customers received the discount, which price the system sent and what instructions controlled the choice. We compare those facts with the payer’s pricing rule and actual payment.

A Rebate Becomes Something Else in the Report

PBM reporting can change the government’s payment even after the prescription has been filled. In the Elixir settlement agreement, the government alleged that the Part D sponsor excluded retained manufacturer rebates from annual reports by classifying them as service fees that did not meet the governing definition. The government alleged that this treatment affected Part D payment reconciliation.

We see the absurdity in the allegation: the rebate disappears from the report because someone calls it a fee. A finance employee may know the receipt, the classification decision and the report built from it.

Which Program Paid the Claim Matters

The payer and the contract tell us which payment obligations to examine. We work through that with you, connecting the pharmacy’s transaction to the plan or government program that funded it.

For Medicare Part D, delegating claims or rebate work to a PBM does not transfer the sponsor’s responsibility to the Centers for Medicare & Medicaid Services. The pharmacy’s claim, the sponsor’s payment data and its rebate report can describe different parts of the same transaction.

Medicaid pharmacy benefits may run through a state program, managed care or a separate pharmacy arrangement. Other insurance can also change who owes the payment. In Caremark’s case, the government alleged that its system canceled Medicaid reimbursement requests when beneficiaries had primary private coverage. An employee who understands those adjustments may see why the state paid another plan’s share.

TRICARE and the Federal Employees Health Benefits Program have their own contracts and payment requirements. Other-insurance decisions can matter to a TRICARE claim. For federal employee benefits, the Office of Personnel Management’s updated pharmacy transparency letter addresses access to claims, pharmacy contracts, manufacturer payments and rebate-processor records for carriers within its scope. We examine the agreement and period involved, including where a PBM handles both public and private plans.

How Does a Pharmacy Whistleblower Case Pay?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. A private person can bring a case for the government under that law, commonly called a qui tam case.

We assess your case with you and the pharmacy or PBM fraud whistleblower lawyers handling the legal work, including any report you have already made.

Medco’s civil settlement required $137.5 million, and the Justice Department announced $23 million in whistleblower awards across the combined cases.

What Can You Explain From Your Role?

Your first conversation can begin with what you personally observed and the records you know exist. A pharmacist, claims analyst, rebate accountant and contract manager see different parts of the business.

An independent pharmacy owner can start with the reimbursement and adjustments visible on the pharmacy side. We assess how that information connects to government payments, including where another department holds the connecting information.

Pharmacy Counter and Dispensing Staff

Pharmacists and technicians may see the original prescription, quantity prepared, pickup or shipment and return to stock. Billing staff may see the original claim, rejection, override, reversal and final remittance. The connection between those records helps explain what the payer funded and what the patient received.

Refill requests and days supply add another layer. The patient’s request, prescribed dose, amount supplied and next refill date can each matter. So can a prior authorization or diagnosis certification: the clinical support and prescriber’s actual approval belong beside the information transmitted for payment. We ask about the instructions behind those entries and what happened when staff questioned them.

Mail-Order and Operations Staff

Mail-order staff may know what arrived in the packing department and what left it. Service staff may know when a prescription first arrived and whether someone actually contacted the physician.

In Medco’s mail-order case, the government alleged short fills, unordered shipments, fabricated physician-contact records and manipulated prescription receipt dates. Its contracts concerned the Federal Employees Health Benefits Program and TRICARE. The government alleged that daily performance reports, monthly invoices and annual statements could misrepresent the underlying work.

A shipping record can establish that a package left the building. The filled quantity and contracted service records explain what the company actually provided. An insider can connect the two.

PBM, Plan and Finance Staff

PBM and plan employees may see both the sponsor’s invoice and the pharmacy’s reimbursement. Others handle manufacturer payments and rebate reconciliations. Spread pricing compares what the sponsor pays the intermediary with what the intermediary pays the pharmacy. Rebate pass-through turns on the contract’s definitions, eligible receipts, exclusions and final reconciliation.

For someone assessing a retained payment, the useful detail is which entity received it, what it was called and where it appeared in the sponsor’s accounting. A payment to make up a rebate shortfall can sit in a different record from the claim. A manufacturer service fee can sit in a different ledger from a rebate.

Part D adds federal reporting. The Centers for Medicare & Medicaid Services describes Prescription Drug Event data as summary extracts rather than individual claim transactions. Federal payment accounting also reaches rebates retained by an intermediary: those receipts can reduce the plan’s drug costs even when the plan does not receive the money. Rebate reports and claim corrections feed the reconciliation after the coverage year, when federal payments are adjusted. Your knowledge of how one file became another may explain why the government paid too much.

Specialty and Institutional Pharmacy Staff

Specialty pharmacy work can connect manufacturer access, patient referrals, refill calls and performance scores. In its Exjade settlement, BioScrip admitted facts about future referrals and refill-pressure communications. Staff who understand how patients were allocated or calls were scored can explain the business incentive behind the conversation with a patient.

Institutional pharmacy adds facility supply contracts, consultant recommendations and prescription-renewal systems. In the government’s Omnicare complaint, a compliance officer described the problem from inside:

The message connects a system capability to the missing professional review. A jury later found Omnicare liable for claims built on invalid prescriptions. For an insider, the warning, the system’s behavior and the claims that followed belong in the same account.

Compounding and Reimbursement Staff

Compounding staff may know the ingredient purchased, formula used, reimbursement pitch and claim sent to the payer. Marketing and reimbursement staff may see referral commissions or how patient copayments were funded. We examine those connections alongside the pharmacy’s knowledge of the pricing and payment arrangement.

The ingredient invoice, advertised reimbursement benchmark and amount actually billed answer different questions. The payer and its reimbursement formula determine why those differences matter. Your understanding of who selected the compound or directed the billing can connect the commercial arrangement to the government claim.

Your Questions Belong in the Conversation

Questions about confidentiality, patient information, employer records or your own role belong in the conversation with us and your pharmacy or PBM fraud whistleblower counsel. We work through those issues with you as part of assessing your case. You can start by explaining the work you did, what you saw and which records would help explain it.

Put Your Knowledge Behind a Case

If you know why a claim stayed paid, a rebate changed categories or a refill went ahead, talk with our whistleblower experts about the decision you saw. We build the case with you and bring in pharmacy and PBM fraud whistleblower lawyers who understand the payment system involved. We remain your partners through the pursuit of the government’s recovery and your whistleblower share.